From Seekingalpha · SA Transcripts · · 40s
Tristel plc Q4 2026 Earnings Call
Tristel plc CEO Chris Lee shares high-level disinfection chemistry results for Q4 2026.
In brief
Tristel plc CEO Chris Lee shares high-level disinfection chemistry results for Q4 2026. Tristel plc's CEO Chris Lee presented Q4 2026 earnings with a focus on chlorine dioxide disinfection technology. Originally reported by Seekingalpha.
Q4 2026 Results
Tristel plc CEO Chris Lee presented Q4 2026 earnings with a focus on chlorine dioxide disinfection technology.
Company Background
Tristel is a chemistry company operating in high-level disinfection with proprietary chlorine dioxide technology to prevent microbial transmission.
CEO Experience
Chris Lee has 35+ years in med tech, including 18 years at Johnson & Johnson and leadership roles at Summit Medical.
At a glance
Tristel plc's CEO Chris Lee presented Q4 2026 earnings with a focus on chlorine dioxide disinfection technology.
